Splenic Siderosis

Description

Splenic siderosis refers to the accumulation of iron in the spleen. This condition typically develops secondary to systemic disorders causing iron overload or chronic haemolytic anaemias. The condition may be associated with splenomegaly and hyperferritinemia, although asymptomatic cases may be discovered incidentally during investigation for other conditions.

Pathogenesis

Splenic siderosis occurs due to the deposition of excess iron within the spleen, often related to increased iron intake or increased release from haemolysed red blood cells. The spleen, a vital component of the reticuloendothelial system, plays a crucial role in recycling iron from damaged or aged red blood cells. Conditions causing haemolysis or iron overload can subsequently lead to splenic siderosis as the iron accumulates in the spleen.

Epidemiology, Risk Factors and Associations

Precise prevalence rates for splenic siderosis are not available due to its relative rarity and often incidental diagnosis. The condition frequently develops secondary to:

  • Chronic haemolytic anaemias, such as thalassaemia and sickle cell disease, which may result in recurrent iron deposition within the spleen.
  • Regular blood transfusions, particularly in conditions like myelodysplastic syndromes, which increase the systemic iron load.
  • Hereditary haemochromatosis, a genetic disorder leading to systemic iron overload.

Clinical Features

Clinical features of splenic siderosis are often related to the underlying cause of iron overload. These may range from asymptomatic cases, discovered incidentally on laboratory tests or imaging, to symptoms related to the primary condition, such as fatigue and jaundice in haemolytic anaemias. Physical examination may reveal splenomegaly.

Complications

The main concern with splenic siderosis is the potential for systemic iron overload syndromes, with iron deposition in organs such as the liver, heart, and pancreas, potentially leading to complications including cirrhosis, cardiomyopathy, and diabetes mellitus, respectively.

Pathological Features

Histopathology usually demonstrates iron deposition within the sinuses and red pulp of the spleen. Iron stains, such as Prussian blue, will highlight these iron deposits.

Radiological Features

The radiological features of splenic siderosis can vary, with spleen size ranging from normal to significantly enlarged, depending on the primary condition.

US
  • Spleen may show increased echogenicity due to iron deposition.
CT
  • Spleen may demonstrate increased attenuation due to iron deposition.
MRI
  • T1: Iron deposits cause a decrease in signal intensity.
  • T2: Decreased signal intensity is again seen due to iron deposition.
  • T2* GRE: Particularly useful to quantify iron content and monitor progression. Appears hypointense to normal tissue.

Differential Diagnosis

Differential diagnosis for splenic siderosis primarily includes other causes of splenomegaly and hyperferritinemia, such as:

  • Haematological malignancies, such as lymphomas and leukaemias.
  • Infections like malaria and leishmaniasis.
  • Other causes of extramedullary haematopoiesis.

Management

Management primarily focuses on addressing the underlying cause of the iron overload. Potential therapeutic strategies may encompass iron chelation therapy, phlebotomy (particularly for haemochromatosis), or tailored management of the haemolytic anaemia. Regular monitoring of ferritin levels and organ function tests (assessing heart, liver, pancreas) is crucial to detect potential systemic iron overload syndromes.

Updated on 5 July 2023

Was this article helpful?